DeepDyve
Login
Login failed. Please try again.
Forgot your password?
Login with Facebook
Close
Please enable Javascript on your browser for a better experience on DeepDyve.
Enter a sentence, or cut and paste a paragraph
Refine
Advanced Filters »
All Edit
Select All | Select None
Reset filters Search
Journals The FASEB Journal November 2009
To view this document, you will need to have Adobe Flash Player 10 or above installed.Please click here to install.
This study investigates the effects of granulocyte colony-stimulating factor (G-CSF) therapy in experimental chronic chagasic cardiomyopathy. Chagas disease is one of the leading causes of heart failure in Latin America and remains without an effective treatment other than cardiac transplantation. C57BL/6 mice were infected with 10 3 trypomastigotes of Trypanosoma cruzi , and chronic chagasic mice were treated with G-CSF or saline (control). Evaluations following treatment were functional, immunological, and histopathological. Comparing hearts of G-CSF-treated mice showed reduced inflammation and fibrosis compared to saline-treated chagasic mice. G-CSF treatment did not alter the parasite load but caused an increase in the number of apoptotic inflammatory cells in the heart. Cardiac conductance disturbances in all infected animals improved or remained stable due to the G-CSF treatment, whereas all of the saline-treated mice deteriorated. The distance run on a treadmill and the exercise time were significantly greater in G-CSF-treated mice when compared to chagasic controls, as well as oxygen consumption ( O 2 ), carbon dioxide production ( CO 2 ), and respiratory exchange ration (RER) during exercise. Administration of G-CSF in experimental cardiac ischemia had beneficial effects on cardiac structure, which were well correlated with improvements in cardiac function and whole animal performance.—Macambira, S. G., Vasconcelos, J. F., Costa, C. R. S., Klein, W., Lima, R. S., Guimarães, P., Vidal, D. T. A., Mendez, L. C., Ribeiro-dos-Santos, R., Soares, M. B. P. Granulocyte colony-stimulating factor treatment in chronic Chagas disease: preservation and improvement of cardiac structure and function.
To view this document, you will need to have Adobe Flash Player 10 or above installed. Please click here to install.
This is a preview. The total pages displayed will be limited.
Rent for $0.99 FREE
It seems like you have an account, please login to rent this article
Don't have an account yet? Sign up now!
To view the full-text of this article, sign up for a free DeepDyve account below.
A free Basic account also comes with 3 free rentals to help get you started.
Just 30 seconds to go! Please check your inbox for a confirmation email to activate your account, then start using your 3 FREE rentals.
Sign up with your Facebook account
Learn more Existing user? Login here
Share this article: facebook twitter
Browse: Subject Areas | Journals | Publishers
© 2010 DeepDyve, Inc. All rights reserved. Terms of Service | Privacy Policy
To bookmark an article, please log in first, or sign up for a DeepDyve account if you don't already have one.
OK
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don't already have one.